ABY-047

N/A

Report date: 2025/01/26 18:30:17
NME

Base Information

Drug NameABY-047
Drug Alias NameHMGB1 inhibitor (Affibody)high mobility group protein B1 inhibitor (Affibody)ABY-047
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHigh Mobility Group Protein B1 inhibitors
TargetsHigh Mobility Group Protein B1
Therapy Area/IndicationsInflammationLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffibody Medical AB
China Registration ClassN/A

Develop Information

Active CompaniesAffibody Medical AB
Inactive CompaniesN/A
Active IndicationsInflammationLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A